Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

City of Hope and BRC treat first patient with BRC-001 in a breast cancer care trial.

cancer patients. City of Hope researchers are evaluating whether this cannabinoid therapeutic candidate could address joint pain (arthralgia) that is often a side effect of aromatase inhibitors, a type of hormone therapy used to treat...

Vaxxas begins a Phase I clinical trial for an H7N9 influenza vaccine using its high-density microarray patch (HD-MAP)

Brandon Capital Partners and US-based HealthCare Ventures, followed by a further financing led by OneVentures with UQ joining the most recent financing.

Solu Therapeutics appoints Sergio Santillana, MD, as Chief Medical Officer to strengthen its leadership team.

Sergio Santillana, MD, MSc, MBA, as Chief Medical Officer (CMO). "As our new chief medical officer, Dr. Sergio Santillana joins our leadership team at a pivotal time as we plan to submit our first IND this year and build new levels of momentum in...

Lunit joins Roche's Digital Pathology Open Environment to advance cancer biomarker testing

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced its collaboration with Roche to integrate Lunit SCOPE PD-L1 22C3 TPS into Roche's navify® Digital Pathology platform. This marks...

IKA introduces new accessories for the HABITAT research bioreactor.

include the Desktop Lid Holder, Sample Flask Holder, Sensor Height Adjustment Adapter, and Condenser with Flexible Joint. These additions offer improved ergonomics, secure handling, and more precise sensor placement, making autoclaving and other...

Corundum Systems Biology appoints Jessica Schneider as Chief Scientific Officer

to market." Dr. Schneider brings almost two decades of experience as a bacterial geneticist and microbiome researcher. She joins Corundum Systems Biology from Takeda Ventures where she managed investment in novel therapeutic modality platforms,...

ProJenX announces the formation of its Clinical Advisory Board

of prosetin in ALS participants. The inaugural ClAB Chair is Angela Genge, MD, FRCP(C), eMBA (McGill University), who is joined by members Jinsy Andrews, MD, MSc (Columbia University), Leonard van den Berg, MD, PhD (UMC Utrecht), and Merit...

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

deployed AI platform in pathology, delivering high-quality solutions that set new standards in healthcare.” Ann Costello Joins Ibex Board of Directors: Ibex welcomed Ann Costello to its Board of Directors in April. With a distinguished career in...

Trinity Life Sciences introduces new customer engagement solutions, leveraging its deep commercial insight and renowned technology platform

them to gain real-world acceptance of their brands and make a difference in patients' lives.​ “It was important for me to join an organization that had the building blocks to create Customer Engagement solutions that combine strategy, insights and...

Bavarian Nordic gets a HERA order and announces a major vaccine donation for the Mpox outbreak in Africa

with HERA since the 2022 mpox outbreak, initially through direct procurement agreements, followed by the signing of a joint procurement agreement which has enabled EU Member States and additional countries in the European Economic Area (EEA) as...

Spencer Trask & Co. launches Signal12 for Dry Eye Disease treatment, led by former Aerie executives, advancing Pro-ocular through trials

decades of experience in ophthalmic product development, FDA and EU submissions, approvals, and market commercialization. Joining Mitro is former Aerie executive Marvin Garrett as senior vice president of regulatory affairs and safety. Garrett has...

Eximia Research Network expands into Virginia by integrating Tidewater Clinical Research

areas, reinforcing its commitment to the community and the pharmaceutical industry at large." Tidewater Clinical Research joins Eximia's growing national network of integrated sites, and their respective practice leaders who welcome the new team as...

Innocan Pharma submits Investigational New Animal Drug application to FDA's Veterinary Center.

and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan has established a Joint Venture by the name of BI Sky Global Ltd. For more information please visit, https://innocanpharma.com/

Cytonics Begins First-In-Human Phase 1 Clinical Study for CYT-108 in Osteoarthritis Knee Patients

activity against the major classes of proteases that are responsible for the majority of cartilage catabolism in arthritic joints, while maintaining its broad-spectrum anti-protease activity against serine and threonine proteases. "Our...

BARDA and Tiba Biotech Collaborate to Develop Next-Gen Influenza Therapeutics

the Collaborative Influenza Vaccine Innovation Centers (CIVICs). Tiba was also recently accepted into BLUE KNIGHT ™, a joint initiative between Johnson & Johnson Innovation – JLABS ('JLABS') and BARDA, with an aim to harness innovation to combat...

Leqembi Secures Approval for Alzheimer's Disease Treatment in Hong Kong

Leqembi in the Nordic region, pending European approval, and currently Eisai and BioArctic are preparing for a joint commercialization in the region. About lecanemab (generic name, brand name: Leqembi®): Lecanemab (Leqembi) is the result of a...

FDA Accepts sBLA Filing of Leqembi® (lecanemab-irmb) for IV Maintenance Dosing in Early Alzheimer's Treatment

lecanemab in the Nordic region, pending European approval, and currently Eisai and BioArctic are preparing for a joint commercialization in the region. About lecanemab (generic name, U.S., Japan and China brand name: Leqembi®) Lecanemab (Leqembi)...

Tempo Therapeutics Appoints Eric I. Richman to Board of Directors

medicine, today announced the addition of Eric I. Richman, MBA to its board of directors. "We are delighted to have Eric join the board at Tempo. His extensive strategic and operational experience paired with his proven track record of success in...

Orthofix Receives FDA 510(k) Clearance for Rodeo™ Telescopic Nail

Europe, and we are pleased to be able to announce this limited U.S. market release during National OI Awareness Week and join in educating others about this genetic bone disorder that is present at birth.” Often referred to as brittle bone disease,...

Tentarix Biotherapeutics announces appointment of Andrew D. Kidd, MD, CFA, as CEO

Tentarix Biotherapeutics announced the appointment of Andrew Kidd, MD, as chief executive officer. Mr. Kidd joins Tentarix with a distinguished career of over two decades of executive and biotech experience. He was most recently the president and...

Results 121 - 140 of 145